How weight loss injections work — the biology behind the results

Step 1 (the injection reaches your gut-hormone receptors within hours

Both tirzepatide and semaglutide are injected into fatty tissue just under the skin) typically the abdomen, outer thigh or upper arm, using a pre-filled pen with a very short, fine needle. After injection, the medicine is absorbed into the bloodstream and binds to specific receptors on cells throughout the gut, pancreas and brain.

Semaglutide targets GLP-1 (glucagon-like peptide-1) receptors. These are part of the system your body uses after a meal to signal fullness, slow the rate at which your stomach empties, and prompt the pancreas to release insulin when blood sugar rises. GLP-1 naturally spikes after eating, but the effect is brief. Semaglutide essentially extends and amplifies that signal, so the 'I've had enough' message persists for much longer than it would after a normal meal.

Tirzepatide does all of that and adds activation of GIP (glucose-dependent insulinotropic polypeptide) receptors. GIP is a second gut hormone involved in energy balance and fat storage. Targeting both pathways at once is what makes tirzepatide the only dual-agonist weight-management medicine licensed in the UK, and it is part of the reason the trial results for tirzepatide sit above those for semaglutide. The NHS medicines page for tirzepatide gives a clear patient-level explanation of this mechanism.

Step 2, appetite changes become noticeable over the first few weeks

Most people notice the appetite effect within the first one to two weeks, though this varies. Food cravings quieten down. Portion sizes that once felt ordinary may start to feel like too much. The sensation of being full arrives earlier in a meal and lingers afterwards. None of this requires willpower to engineer, the medicine is changing the signalling environment your brain is operating in.

Gastric emptying slows as part of the same process. Food moves through the stomach more gradually, which contributes to both the fullness effect and, early on, some of the gastrointestinal side effects people experience: nausea, a feeling of fullness even when not eating much, occasional burping or constipation. These are typically most noticeable in the first days after a new dose and settle for most people within a week or two. The side effects are a sign the medicine is active, not a sign something has gone wrong, though your prescriber should know if they are persistent or severe.

If you are curious about how quickly the results become measurable, that is worth reading separately, the timeline for visible weight change differs from the timeline for appetite change.

Step 3, dose titration lets the effect build safely

Treatment does not start at full strength. Mounjaro begins at 2.5mg; the first pen's job is to let your digestive system adjust, with your prescriber reviewing progress before considering a dose increase, typically after four weeks. Wegovy follows a similar pattern, starting at 0.25mg and working upward through the schedule at roughly monthly intervals. The prescriber, not the patient, decides when a step up is appropriate.

This is why clinical oversight matters throughout treatment, not just at the start. A prescriber who reviews your case before every repeat order is doing more than ticking a box, they are checking that the current dose is still appropriate, that side effects are manageable, and that weight loss is progressing in a way that is sustainable. At nume, every repeat order goes through fresh clinical review by a GPhC-registered Independent Prescriber before anything is dispensed.

For a fuller picture of how the two licensed options compare, the weight loss injections overview sets out the key differences in plain terms. If cost is a consideration, there is also practical context on what affects pricing worth reading before you make any decisions.

Do weight loss injections actually work? What the evidence shows

The short answer is yes, for the people the trials studied, adults with obesity or with a weight-related health condition, who were also making dietary and activity changes. The SURMOUNT-1 trial, published in the New England Journal of Medicine, found that tirzepatide at 15mg produced an average body-weight reduction of around 20–21% over 72 weeks. STEP 1, the equivalent trial for semaglutide 2.4mg, found around 15% average reduction over 68 weeks. Both figures are in people without type 2 diabetes, and if you want to understand how weight loss injections work at a biological level, that context helps make sense of why the results look the way they do.

These are prescription medicines assessed by NICE, whose appraisal of tirzepatide (TA1026) confirmed that the clinical evidence supports use in eligible adults. NICE sets NHS eligibility thresholds (BMI 35 or above with a qualifying health condition, in the current rollout phase), but private prescribing follows the licensed criteria, which are broader: adults with a BMI of 30 or above, or 27 or above with a weight-related condition such as high blood pressure, high cholesterol or type 2 diabetes.

Timing matters in a practical sense too. A Monday order placed before 12pm, if approved, leaves our pharmacy the same day. If you are planning treatment around a holiday or a particularly busy month, it is worth reading about how long weight loss injections take to work, since understanding the expected timeline helps you plan realistically, and the medicines need refrigeration at home, so storage logistics are part of the conversation at consultation. It is also worth knowing that the period before weight loss injections produce noticeable results can vary between individuals, which is another reason clinical review at each stage makes a difference.

Whether these medicines are right for you depends on your medical history, current medications and personal circumstances. Speaking to our prescribers is the proper next step, the consultation is free, and a real clinician reads every response the same day.